Capital Advisors Ltd’s Cross Country Healthcare CCRN Stock Holding History

Capital Advisors Ltd’s Portfolio CCRN Stock Details CCRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6	Closed	–	–	1036
2022 Q1	$0	Buy	+6	New	+$130	﹤0.01%	930

Other funds holding CCRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SCM

Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Capital Advisors Ltd's CCRN Position: Q2 2022 in Review

Capital Advisors Ltd sold out of Cross Country Healthcare (CCRN) in Q2 2022, closing a stake of 6 shares.

Capital Advisors Ltd first reported a position in CCRN in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 181 funds tracked by Wall St. Rank hold CCRN as of Q2 2022.

Capital Advisors Ltd reported no remaining Cross Country Healthcare position as of Q2 2022 after selling out during the quarter.
Capital Advisors Ltd sold 6 Cross Country Healthcare shares in Q2 2022.
Capital Advisors Ltd first reported a position in Cross Country Healthcare in Q1 2022 and held it in 1 quarter.
Capital Advisors Ltd's Cross Country Healthcare position peaked at $0 in Q1 2022.
181 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2022.

Based on Capital Advisors Ltd's 13F filing for Q2 2022, filed 5 Aug 2022.